Prf technologies ltd.PRFX.US Overview

US StockHealthcare

(No presentation for PRFX)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

PRFX Overall Performance

PRFX AI Analysis & Strategy

PRFX Recent Performance

-6.25%

Prf technologies ltd.

0.81%

Avg of Sector

-1.14%

S&P500

PRFX PowerScanner

PRFX Key Information

PRFX Valuation Metrics

PRFX Earnings Table

PRFX Profile

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.